Samuel Bennett

Director - Search & Evaluation at Novo Nordisk

Speaker

Physician and pharmaceutical BD lead with 12+ years of experience spanning biopharma business development & strategy, venture capital, biotech consulting, and clinical medicine. As Director, Search & Evaluation within Global Business Development at Novo Nordisk, he focus’s upon building external innovation strategy across cardiometabolic disease and then identifying and executing strategic deals (inc. M&A, licensing, option deals, equity investments etc.). His expertise spans leadership of diligence and transaction execution (including leading the recent acquisition of Akero Therapeutics), asset valuation, translational & clinical medicine, clinical development, commercial strategy, and investment committee decision-making.